I'll just wait on Integrated Plasmonics to ship something. Cue might have fit some market with existing tech, but it looks pretty niche. "Deep" monitoring...a

I'll just wait on Integrated Plasmonics to ship something. Cue might have fit some market with existing tech, but it looks pretty niche. "Deep" monitoring...and then testosterone. Wonderful. I'll know if lifting weights really affects testosterone levels while completely missing that prostate cancer on the way. We have deep testing. We don't have broad or cheap testing. The fact that the tests aren't cheap, (fertility???) and the marketing strikes me as pretending existing things are new makes me think this is investment fodder. I didn't wake up today decided to be negative. The product gives me signals that seem to betray a lack of sincerity in terms of delivering anything with truly new value propositions.